David H. Li
Known title: President & CEOCIK: 0001436880
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Ingevity sets Q3 2026 earnings date; article discusses holding reasons. Ingevity announced the dates for its third‑quarter 2026 earnings release and the accompanying webcast. A recent Yahoo article outlined several points that investors have cited for maintaining their positions in the company. The upcoming earnings call may provide additional data that could influence market views.
Transaction History
| HXL | ▲ Buy | Option Exercise | 340 | $0 | 10/3/2026 | View on chart |
| NGVT | ▼ Sell | Open Market | 92 | $7K | 8/18/2026 | View on chart |
| NGVT | ▼ Sell | Open Market | 5,000 | $379K | 8/17/2026 | View on chart |
| NGVT | ▼ Sell | Open Market | 5,000 | $379K | 8/14/2026 | View on chart |
| NGVT | ▼ Sell | Open Market | 5,000 | $379K | 8/13/2026 | View on chart |
| NGVT | ▼ Sell | Open Market | 5,000 | $383K | 8/12/2026 | View on chart |
| HXL | ▲ Buy | Option Exercise | 373 | $0 | 7/10/2026 | View on chart |
| HXL | ▲ Buy | Option Exercise | 2,697 | $0 | 5/8/2026 | View on chart |
| NGVT | ▼ Sell | Tax Withholding | 13,102 | $925K | 4/7/2026 | View on chart |
| NGVT | ▼ Sell | Tax Withholding | 3,574 | $252K | 4/7/2026 | View on chart |
| HXL | ▲ Buy | Option Exercise | 457 | $0 | 4/4/2026 | View on chart |
| NGVT | ▲ Buy | Grant | 38,179 | $0 | 2/27/2026 | View on chart |
| HXL | ▲ Buy | Option Exercise | 341 | $0 | 1/10/2026 | View on chart |
| HXL | ▲ Buy | Option Exercise | 744 | $0 | 5/7/2025 | View on chart |
| NGVT | ▲ Buy | Grant | 86,669 | $0 | 4/7/2025 | View on chart |
| NGVT | ▲ Buy | Grant | 31,516 | $0 | 4/7/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Wells Fargo Lowers Hexcel Price Target to $105
Wells Fargo maintained its Overweight rating on Hexcel but reduced its price target to $105. The company also announced the schedule for its third-quarter 2026 earnings release. These updates provide new reference points for investors following Hexcel's recent performance.
Wells Fargo Lowers Hexcel Price Target to $105. Wells Fargo maintained its Overweight rating on Hexcel but reduced its price target to $105. The company also announced the schedule for its third-quarter 2026 earnings release. These updates provide new reference points for investors following Hexcel's recent performance.